Rachel Vaknin
2023
In 2023, Rachel Vaknin earned a total compensation of $289.5K as CFO at StemCells, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $27,626 |
|---|---|
| Option Awards | $76,533 |
| Salary | $139,601 |
| Other | $45,743 |
| Total | $289,503 |
Vaknin received $139.6K in salary, accounting for 48% of the total pay in 2023.
Vaknin also received $27.6K in bonus, $76.5K in option awards and $45.7K in other compensation.
Rankings
In 2023, Rachel Vaknin's compensation ranked 2,509th out of 2,918 executives tracked by ExecPay. In other words, Vaknin earned more than 14.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,509 out of 2,918 | 14th |
Division Manufacturing | 1,402 out of 1,608 | 13th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 214 out of 252 | 15th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 154 out of 184 | 16th |
Industry Surgical and Medical Instruments and Apparatus | 123 out of 144 | 15th |
Source: SEC filing on November 6, 2024.
Vaknin's colleagues
We found three more compensation records of executives who worked with Rachel Vaknin at StemCells in 2023.